Jove
Visualize
Contact Us

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

884
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
884
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

892
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
892
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

705
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
705
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

763
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
763

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Underwater Suit-Wearing Cyborg Insect Capable of Hours-Long Diving and Terra-Aqua Travel.

Nature communications·2026
Same author

A contractile force measurement system for hiPSC-derived cardiac tissue integrated with an ultrathin, stretchable nanomesh.

Lab on a chip·2026
Same author

Beat-to-beat variability of ventricular repolarization reveals sex-specific instability and proarrhythmic risk.

The Journal of physiology·2026
Same author

Beat-to-beat QT interval variability as a tool to detect the underlying cellular mechanisms of arrhythmias.

The Journal of physiology·2025
Same author

Role of Dynamical Instability in QT Interval Variability and Early Afterdepolarization Propensity.

bioRxiv : the preprint server for biology·2025
Same author

Metal-Plastic Hybrid Additive Manufacturing to Realize Small-Scale Self-Propelled Catalytic Engines.

ACS omega·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 29, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

9.9K

Fibroblast Density is a Risk Factor for Drug-induced Arrhythmias.

Kayo Hirose, Shinjiro Umezu, Daisuke Sato

    Biorxiv : the Preprint Server for Biology
    |February 3, 2025
    PubMed
    Summary

    Fibroblasts influence drug-induced arrhythmias, with a biphasic effect of fibrosis density on premature ventricular complexes (PVCs). Increased fibrosis density enhances arrhythmia self-sustainability, highlighting the interplay between fibrosis and action potential duration heterogeneity.

    More Related Videos

    A Cost Effective and Adaptable Scratch Migration Assay
    08:59

    A Cost Effective and Adaptable Scratch Migration Assay

    Published on: June 30, 2020

    5.3K
    Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
    08:03

    Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

    Published on: October 20, 2022

    1.7K

    Related Experiment Videos

    Last Updated: May 29, 2025

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
    10:21

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

    Published on: June 14, 2016

    9.9K
    A Cost Effective and Adaptable Scratch Migration Assay
    08:59

    A Cost Effective and Adaptable Scratch Migration Assay

    Published on: June 30, 2020

    5.3K
    Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
    08:03

    Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

    Published on: October 20, 2022

    1.7K

    Area of Science:

    • Cardiovascular Physiology
    • Computational Biology
    • Cardiac Electrophysiology

    Background:

    • Repolarization heterogeneity is crucial for initiating and maintaining cardiac arrhythmias.
    • Fibroblasts are integral to cardiac structure and can alter myocardial electrical properties.
    • The specific role of fibroblasts in arrhythmia development, particularly with diffuse fibrosis, requires further investigation.

    Purpose of the Study:

    • To investigate the contribution of diffuse fibrosis to focal and reentrant arrhythmias under drug-induced heterogeneity.
    • To model the effects of varying fibroblast densities (FD) on premature ventricular complexes (PVCs) and arrhythmia self-sustainability.
    • To elucidate the interplay between diffuse fibrosis and drug-induced action potential duration (APD) heterogeneity in ventricular arrhythmias.

    Main Methods:

    • Utilized physiologically detailed mathematical models of human cardiac tissue (2D and 3D).
    • Simulated drug-induced heterogeneity by altering transmembrane potassium and calcium current conductance, affecting APD.
    • Assessed the impact of diverse fibrosis densities (0-35%) on PVC occurrence and arrhythmia self-sustainability.

    Main Results:

    • A biphasic relationship was observed between fibrosis density (FD) and drug-induced PVCs: susceptibility increased with FD up to a certain threshold, then decreased.
    • Excessively high fibrosis levels (>30%) were associated with reduced PVC occurrence.
    • The self-sustainability of arrhythmias, including ventricular fibrillation (VF), consistently increased with higher FD.

    Conclusions:

    • Diffuse fibrosis plays a complex role in the genesis of ventricular arrhythmias under drug-induced heterogeneity.
    • Fibroblasts can promote PVCs within a specific range of fibrosis density but may reduce their occurrence at very high densities.
    • Increased fibrosis density enhances the maintenance and self-sustainability of cardiac arrhythmias, suggesting distinct roles in initiation versus perpetuation.